Related Experiment Video
Updated: Jul 10, 2025
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.8K
Virtual clinic for young people with type 1 diabetes: a randomised wait-list controlled study
Janeth Leksell1, Eva Toft2,3, Jessica Rosman4
1Department of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, Akademiska sjukhuset, Uppsala, SE-75185, Sweden. Janeth.Leksell@medsci.uu.se.
BMC Endocrine Disorders
|November 22, 2023
Summary
Virtual diabetes clinics show promise for improving quality of life in young adults with type 1 diabetes, though glycaemic control and treatment satisfaction did not significantly change. Further research is needed for long-term effects.
Area of Science:
- Endocrinology
- Digital Health
- Adolescent Medicine
Background:
- Transitioning paediatric to adult care for type 1 diabetes presents challenges.
- Virtual diabetes clinics offer a novel approach for self-management and provider communication.
- Smartphone applications can support young adults with type 1 diabetes.
Purpose of the Study:
- To evaluate the impact of a virtual diabetes clinic on glycaemic control.
- To assess changes in treatment satisfaction and quality of life.
- To examine the effects on young adults with type 1 diabetes.
Main Methods:
- A prospective, single-centre, randomised, wait-list controlled trial.
- 79 participants (18-25 years) with type 1 diabetes were randomised.
- Intervention group used the Vista Dialog virtual care platform for 6 months.
Main Results:
- No significant differences in HbA1c, time in range, or time below range.
- Diabetes treatment satisfaction remained unchanged between groups.
- The intervention group reported a significant reduction in physical health burden, improving quality of life.
Conclusions:
- Virtual diabetes clinics did not significantly improve glycaemic control or treatment satisfaction.
- The Vista Dialog platform showed potential in enhancing quality of life for young adults with type 1 diabetes.
- Further investigation is required to determine long-term benefits and optimal implementation.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
01:16Insulin: Dosing Regimen and Adverse Effects
182
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
182
01:22Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
01:15Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
01:15Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554